| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10019602 | HBV | ENSG00000198785.7 | protein_coding | GRIN3A | No | No | 116443 | Q8TCU5 |
| TVIS10018253 | HBV | ENSG00000198785.7 | protein_coding | GRIN3A | No | No | 116443 | Q8TCU5 |
| TVIS10005829 | HBV | ENSG00000198785.7 | protein_coding | GRIN3A | No | No | 116443 | Q8TCU5 |
| TVIS10005828 | HBV | ENSG00000198785.7 | protein_coding | GRIN3A | No | No | 116443 | Q8TCU5 |
| TVIS10033234 | HBV | ENSG00000198785.7 | protein_coding | GRIN3A | No | No | 116443 | Q8TCU5 |
| TVIS10036190 | HBV | ENSG00000198785.7 | protein_coding | GRIN3A | No | No | 116443 | Q8TCU5 |
| TVIS10019936 | HBV | ENSG00000198785.7 | protein_coding | GRIN3A | No | No | 116443 | Q8TCU5 |
| TVIS10020135 | HBV | ENSG00000198785.7 | protein_coding | GRIN3A | No | No | 116443 | Q8TCU5 |
| TVIS10042400 | HBV | ENSG00000198785.7 | protein_coding | GRIN3A | No | No | 116443 | Q8TCU5 |
| TVIS10062547 | HBV | ENSG00000198785.7 | protein_coding | GRIN3A | No | No | 116443 | Q8TCU5 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | GRIN3A |
|---|---|
| DrugBank ID | DB00142 |
| Drug Name | Glutamic acid |
| Target ID | BE0000641 |
| UniProt ID | Q8TCU5 |
| Regulation Type | |
| PubMed IDs | 16641235 |
| Citations | Yao Y, Mayer ML: Characterization of a soluble ligand binding domain of the NMDA receptor regulatory subunit NR3A. J Neurosci. 2006 Apr 26;26(17):4559-66. doi: 10.1523/JNEUROSCI.0560-06.2006. |
| Groups | Approved; Nutraceutical |
| Direct Classification | Glutamic acid and derivatives |
| SMILES | N[C@@H](CCC(O)=O)C(O)=O |
| Pathways | Histidinemia; Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); 3-Methylglutaconic Aciduria Type I; beta-Ketothiolase Deficiency; Purine Nucleoside Phosphorylase Deficiency; Tyrosine Metabolism; Ketoprofen Action Pathway; Glutamate Metabolism; Argininosuccinic Aciduria; Salla Disease/Infantile Sialic Acid Storage Disease; Tyrosinemia Type I; Hyperinsulinism-Hyperammonemia Syndrome; 2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency; Glutaric Aciduria Type I; Propanoate Metabolism; Celecoxib Action Pathway; Glycine and Serine Metabolism; Suprofen Action Pathway; Indomethacin Action Pathway; Carbamoyl Phosphate Synthetase Deficiency; Sialuria or French Type Sialuria; Ibuprofen Action Pathway; Saccharopinuria/Hyperlysinemia II; Histidine Metabolism; Arginine and Proline Metabolism; Purine Metabolism; Diflunisal Action Pathway; Etodolac Action Pathway; Ammonia Recycling |
| PharmGKB | PA449776 |
| ChEMBL | CHEMBL575060 |
